About Medley Pharmaceuticals
Medley Pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 1969 by Sahir Khatib, Sarosh Sami Khatib, and Suhel Sami Khatib. Over-the-counter drugs, APIs, and other pharmaceuticals are manufactured by Medley. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Medley Pharmaceuticals has raised $39.46 thousand across 1 funding round from investors including K A Syed, Supriyo Lahiry and Syed Quazi. The company has 2,852 employees. Medley Pharmaceuticals was last valued at $76.23 million in March 2012. Its Indian entity Medley Pharmaceuticals Limited reported revenue of ₹1,115 Cr. Medley Pharmaceuticals offers products and services including Suprakare, Nutrakare, Vazokare, Glycekare, and Osteokare. Its focus areas include Pharmaceuticals and Drug Manufacturing.
Company details
Medley Pharmaceuticals is involved in the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company operates across various therapeutic segments including analgesics, anti-inflammatory drugs, antibiotics, anti-diabetics, and anti-hypertensive medications. Facilities are maintained with high-quality standards adhering to Good Manufacturing Practices (GMP). Operations are supported by state-of-the-art infrastructure in multiple locations across India and international collaborations in regions like South East Asia, Middle East, Africa, CIS, and Europe. Solutions are provided through divisions such as Suprakare, Nutrakare, Vazokare, Glycekare, and Osteokare, addressing diverse healthcare needs.
- Headquarters Mumbai, India
- Employees 2,852
- Founders Sahir Khatib, Sarosh Sami Khatib, Suhel Sami Khatib
- Stage Minicorn
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website medleylab.com
- Social LinkedIn
- Legal Name Medley Pharmaceuticals Ltd.
- Date of Incorporation 15 Apr, 1975
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1,115 Cr
FY 2025 · +8% YoY
- Net Profit₹248 Cr
FY 2025 · 22% margin
- EBITDA₹356 Cr
FY 2025 · 32% margin
- Total Equity Funding$39.46K (USD)
in 1 rounds
- Latest Funding Round$39.46K (USD), Angel Round
Mar 2012
- Employee Count2,852
Associated legal entities of Medley Pharmaceuticals
Medley Pharmaceuticals operates through Medley Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medley Pharmaceuticals Limited CIN U24230MH1975PLC018296 | Active | 15 Apr 1975 | Mumbai, Maharashtra | ₹1,115 Cr | 2,852 | 10 | View details |
Products & Services of Medley Pharmaceuticals
Medley Pharmaceuticals offers a comprehensive portfolio of products and services, including Suprakare, Nutrakare, Vazokare, Glycekare, and Osteokare.
Products for analgesic and anti-inflammatory treatments are offered.
Haematinic and anti-infertility solutions are provided by Nutrakare.
Anti-hypertensive and anti-diabetic drugs are included in Vazokare.
Anti-diabetic and lipid-lowering agents are offered by Glycekare.
Anti-osteoporotic and muscle relaxant products are provided here.
Funding Insights of Medley Pharmaceuticals
Medley Pharmaceuticals has successfully raised a total of $39.46K through 1 strategic funding round. The most recent funding activity was a Angel Round of $39.46 thousand completed in March 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $39,458
- Total Rounds 1
- Last Round Angel Round — $39,458
- First Round $39,458
(Mar 2012)
- Investors Count 14
All 1 funding rounds of Medley Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2012 | $39,458 | Angel Round | $76.23M | Surendra Kumar Sharma, Tarun Gupta |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2012 | $76.23M | •••••••• |
Last known valuation $76.23M (Mar 2012). 14 investors in total: 0 institutional and 14 angel.
Investors in Medley Pharmaceuticals
Medley Pharmaceuticals has secured backing from 14 investors, including angel investors. Prominent investors backing the company include K A Syed, Supriyo Lahiry and Syed Quazi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
KA K A Syed | unknown_def575b1e13840718 | |||
SL Supriyo Lahiry | unknown_db7c7151cdac48ca9 | |||
SQ Syed Quazi | unknown_dc213240c6354637a | |||
RD Raju Deshmukh | unknown_abe17415522944ef9 | |||
VA Vikash Anand | Angel investor and entrepreneur, focused on tech startups in India. | unknown_69c2b90bfdd840adb | ||
FT Firdaus Tarachand | unknown_996fc3d850924a29b | |||
AK Azeem Kunde | unknown_df761ebc47e24159a | |||
AF Arif Faruqui | unknown_99435297b76e4bdba | |||
WA Wasif Ali | unknown_4f837d597ac642c2b | |||
DG Dilip Ghodekar | unknown_1cc9ff3cb15744f58 |
Investor details for Medley Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Medley Pharmaceuticals Limited (Medley Pharmaceuticals)
Medley Pharmaceuticals Limited is the primary company behind Medley Pharmaceuticals. The board of Medley Pharmaceuticals Limited currently have 8 directors; the longest-serving is Sarosh Sami Khatib, appointed in 1987. 21 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sarosh Sami Khatib DIN 00058143 | Whole-time director | 17 Jul 1987 | 39 yrs 3 mo | Medley Pharmaceuticals Limited |
| Mirasif Mirmohsin Ali DIN 00058250 | Whole-time director | 27 Sep 1999 | 27 yrs | Medley Pharmaceuticals Limited |
| Suhel Sami Khatib DIN 00904454 | Director | 01 Apr 2010 | 16 yrs 6 mo | Medley Pharmaceuticals Limited |
| Ravindra Baliram More DIN 03088033 | Company Secretary | 01 Dec 2014 | 11 yrs 10 mo | Medley Pharmaceuticals Limited |
| Saba Mir Asif Ali DIN 00058184 | Whole-time director | 24 Feb 2015 | 11 yrs 7 mo | Medley Pharmaceuticals Limited |
| Sahir Sami Khatib DIN 00043681 | Managing Director | 01 Apr 2015 | 11 yrs 6 mo | Medley Pharmaceuticals Limited |
| Mohamed Aslam Abdul Rahman Sheikh DIN 03215349 | Director | 28 Jun 2024 | 2 yrs 3 mo | Medley Pharmaceuticals Limited |
| Sucheta Mudgerikar DIN 10720060 | Director | 25 Jul 2024 | 2 yrs 2 mo | Medley Pharmaceuticals Limited |
People of Medley Pharmaceuticals
51 people are tracked at Medley Pharmaceuticals (12 in leadership, 6 in board & advisors, 33 in team); the tracked headcount is 2,852.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
Shailesh Naik | General Manager Marketing - Ortho & Pain Management | Leadership |
Devendra Bhagat | CFO | Leadership |
Ca Devendra Bhagat | Vice President - Finance & Accounts | Leadership |
Azeem Abdul | Vice-president Sales & Marketing | Leadership |
Dr.a.a Faruqui | Sr.vice President-medical | Leadership |
Surinder Bhasin | General Manager, Quality Operations | Leadership |
Supriyo Lahiry | Senior Vice President Domestic Business | Leadership |
Ritesh Paltani Plethico | Director Generic Business | Leadership |
Jagannadha Rao Bodapati | Vice President | Leadership |
| Chairman | Board & advisors | |
| Director | Board & advisors | |
| Deputy Chairman | Board & advisors | |
Mushtaq Antulay | Independent Director | Board & advisors |
Shuaib Fakih | Independent Director | Board & advisors |
| Company Secretary | Board & advisors | |
Akshay More | Medical Sales Representative | Team |
Ashish Kumar | Medical Representative | Team |
31 more people are available in the full profile.
Complete people profiles for Medley Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Medley Pharmaceuticals
Figures of Medley Pharmaceuticals Limited, the primary company behind Medley Pharmaceuticals, for FY 2025. Revenue was ₹1,115 Cr (+8% year on year). Net profit was ₹248 Cr (22% margin). EBITDA was ₹356 Cr (32% margin). Revenue has grown at a compounded annual rate of +7% over three years and +9% over five years.
- ₹1,115 CrRevenue · FY 2025 · +8% YoY
- ₹248 CrNet profit · 22% margin
- ₹356 CrEBITDA · 32% margin
- ₹30.06 CrPaid-up capital
- 2,852Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Medley Pharmaceuticals Limited are on its company page.
Detailed financial statements for Medley Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Medley Pharmaceuticals
3 dated milestones of Medley Pharmaceuticals across 43 years, from founding to its latest funding, stage changes and deals.
- Founded Medley Pharmaceuticals is founded.
- Funding First funding round of $39K.
- Milestone Reaches Minicorn status.
Web traffic of Medley Pharmaceuticals
The website of Medley Pharmaceuticals (medleylab.com) receives about 4.3K visits a month and ranks #4,990,920 among all websites worldwide, #5,790 in Biotechnology and Pharmaceuticals.
- Monthly visits4.3K
▲ 26.5% vs previous month
- Unique visitors1.5K
per month
- Global rank#4,990,920
among all websites
- Category rank#5,790
Health · Biotechnology and Pharmaceuticals
- Bounce rate44%
- Pages per visit1.7
- Average visit29 sec
- DevicesDesktop 46% · Mobile 54%
Websites whose visitors overlap most with Medley Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| indoco.com | 100% | 11.8K | #1,452,218 | View details | |
| ajantapharma.com | 93% | 20.1K | #1,412,069 | View details | |
| mangalamdrugs.com | 92% | 9.9K | #1,747,627 | View details | |
wingsbiotech.com | wingsbiotech.com | 90% | – | ||
| cironpharma.com | 90% | 2.4K | #7,858,699 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Medley Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Medley Pharmaceuticals (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medley Pharmaceuticals
Complete news archive for Medley Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medley Pharmaceuticals
Medley Pharmaceuticals was founded in 1969 and raised its 1st funding round 43 years after it was founded.
Medley Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Medley Pharmaceuticals is a funded company, having raised a total of $39.46K across 1 funding round to date. The company's 1st funding round was a Angel Round of $39.46K, raised on Mar 2012.
Medley Pharmaceuticals has 2,852 employees.
The primary company behind Medley Pharmaceuticals, Medley Pharmaceuticals Limited, reported revenue of ₹1,115 Cr for FY 2025, up 8% year on year.
Medley Pharmaceuticals is involved in the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company operates across various therapeutic segments including analgesics, anti-inflammatory drugs, antibiotics, anti-diabetics, and anti-hypertensive medications. Facilities are maintained with high-quality standards adhering to Good Manufacturing Practices (GMP). Operations are supported by state-of-the-art infrastructure in multiple locations across India and international collaborations in regions like South East Asia, Middle East, Africa, CIS, and Europe. Solutions are provided through divisions such as Suprakare, Nutrakare, Vazokare, Glycekare, and Osteokare, addressing diverse healthcare needs.
Medley Pharmaceuticals offers Suprakare, Nutrakare, Vazokare, Glycekare, and Osteokare.
Medley Pharmaceuticals has 14 investors. Key investors include K A Syed, Supriyo Lahiry, Syed Quazi, Raju Deshmukh, and Vikash Anand.
The valuation of Medley Pharmaceuticals is $76.23M as of Mar 2012.
Medley Pharmaceuticals operates through Medley Pharmaceuticals Limited.
The legal entities of Medley Pharmaceuticals currently have 9 directors, including Ravindra Baliram More, Sahir Sami Khatib, Devendra Pandurang Bhagat and others.